CompoAtlas

PLX Powder

Natural health product licensed in Canada

Licence holder
CK Ingredients Inc.
NPN or DIN-HM
80069564
Status
Active licence
Licence date
19 May 2016
Revision date
Not provided
Form
Poudre
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Aloysia citrodora

Source : Aloysia citrodora - Feuille

Extract : Matériel brut sec

Extraction ratio : 20:1

Dry plant equivalent : 21.6 g

1.08 gNot calculated

Non-medicinal ingredients

Maltodextrine

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Portion(s)1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

PLX TM helps for the management of joint discomfort due to sport injury. PLX TM improves lipid profile (HDL). PLX TM when taken by healthy persons in combination with regular exercise, helps decrease muscular (myoglobin) and hepatic (gamma-glutamyl transferase) damage markers. PLX TM helps to increase the activity of antioxidant enzyme catalase (lymphocytes and erythrocytes) when combined with regular exercise. PLX TM consumption helps increase the activity of glutathione dependent antioxidant enzymes in erythrocytes when combined with regular exercise.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80069564

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line